Activation of GPR39 Ameliorates Placental Dysfunction by Inhibiting Activation of NLRP1 Inflammasome in Gestational Diabetes Mellitus

View Full Paper

Ask AI

Bookmark

Authors

Discussion

Experiments reveal GPR39 agonist TC‐G 1008 improves fetal outcomes and reduces inflammation in gestational diabetes.

Activation of GPR39 by TC‐G 1008 improves fetal outcomes in gestational diabetes mellitus.
GPR39 expression was significantly lower in GDM mice compared to wild-type controls, indicating dysfunction.
The study utilized a high-fat diet-induced GDM mouse model to analyze the effects of GPR39 activation.
Findings suggest GPR39 activation may serve as an effective therapeutic strategy for managing complications of GDM.

Zhou et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

View Full Paper

Ask AI

Bookmark

Authors

Experiments reveal GPR39 agonist TC‐G 1008 improves fetal outcomes and reduces inflammation in gestational diabetes.

Activation of GPR39 by TC‐G 1008 improves fetal outcomes in gestational diabetes mellitus.
GPR39 expression was significantly lower in GDM mice compared to wild-type controls, indicating dysfunction.
The study utilized a high-fat diet-induced GDM mouse model to analyze the effects of GPR39 activation.
Findings suggest GPR39 activation may serve as an effective therapeutic strategy for managing complications of GDM.

Zhou et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark